PharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust's other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.
2011年2月10日澳洲股市报告包括：Calzada (ASX:CZD)宣布人类骨骼生长干细胞研究取得积极结果；PharmAust Limited (ASX:PAA)将收购欧洲高品位贵金属和基础金属项目；Northern Star Resources (ASX:NST)宣布西澳黄金生产强劲结果；Latin Resources Limited (ASX:LRS)将收购秘鲁14,068公顷的世界级铁及重矿砂矿权地。
ABN Newswire今天的股票看点包括：iSOFT Group Limited (ASX:ISF)、AuDAX Resources Limited (ASX:ADX) (PINK:ADXRF)、Clean Global Energy Limited (ASX:CGV)和Brickworks Limited (ASX:BKW)。
